Cell-specific CRISPR-Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins

Abstract. The rapid development of CRISPR-Cas technologies brought a personalized and targeted treatment of genetic disorders into closer reach. To render CRIS

Saved in:
Bibliographic Details
Main Authors: Hoffmann, Mareike (Author) , Aschenbrenner, Sabine (Author) , Große, Stefanie (Author) , Rapti, Kleopatra (Author) , Domenger, Claire (Author) , Fakhiri, Julia (Author) , Mastel, Manuel (Author) , Börner, Kathleen (Author) , Eils, Roland (Author) , Grimm, Dirk (Author) , Niopek, Dominik (Author)
Format: Article (Journal)
Language:English
Published: 15 April 2019
In: Nucleic acids research
Year: 2019, Volume: 47, Issue: 13
ISSN:1362-4962
DOI:10.1093/nar/gkz271
Online Access:Verlag, Volltext: https://doi.org/10.1093/nar/gkz271
Verlag, Volltext: https://academic.oup.com/nar/article/47/13/e75/5458120
Get full text
Author Notes:Mareike D. Hoffmann, Sabine Aschenbrenner, Stefanie Grosse, Kleopatra Rapti, Claire Domenger, Julia Fakhiri, Manuel Mastel, Kathleen Börner, Roland Eils, Dirk Grimm, Dominik Niopek
Description
Summary:Abstract. The rapid development of CRISPR-Cas technologies brought a personalized and targeted treatment of genetic disorders into closer reach. To render CRIS
Item Description:Gesehen am 03.01.2020
Physical Description:Online Resource
ISSN:1362-4962
DOI:10.1093/nar/gkz271